Employer profile
Adaptive Phage Therapeutics
2 certified H-1B filings across 2 fiscal years.
Snapshot year
FY2024 filings
1
FY2024 median
$129k
Top role
Project Manager, Project & Alliance Management
2 filings · all-time
Top state
MD
2 filings · all-time
Pay distribution
How Adaptive Phage Therapeutics pays, by fiscal year
Each box is the p25–p75 interquartile range; the heavy line is the median and the whiskers reach p10–p90. Base salary only — hover a year for its figures.
Year-over-year
How Adaptive Phage Therapeutics hired across H-1B fiscal years. The small figure under each filings count is its change vs the prior FY.
| FY | Filings | Median $ |
|---|---|---|
| FY2024 | 10% | $129k |
| FY2022 | 1— | $115k |
Prevailing wage level distribution
DOL Levels I–IV approximate experience tiers (I = entry, IV = fully competent). A heavy Level I/II skew suggests entry-level / contractor-style hiring; a heavy IV skew suggests senior in-house roles.
Lvl I
2100%
Top job titles
Most-filed positions, across all years (raw DOL titles).
| Job Title | Filings | Median |
|---|---|---|
| Project Manager, Project & Alliance Management | 2 | $115k |
Top worksite states
Where this employer files.
| State | Filings | Median |
|---|---|---|
| MD | 2 | $115k |
Related employers
Similar H-1B volume
Frequently asked questions
- How much does Adaptive Phage Therapeutics pay H-1B workers?
- Adaptive Phage Therapeutics's median certified H-1B base salary is $129k (FY2024), from 1 filings. See the full salary distribution and percentiles above.
- How many H-1B workers does Adaptive Phage Therapeutics sponsor?
- Adaptive Phage Therapeutics has 2 certified H-1B Labor Condition Applications on record (FY2022–FY2024).
- What jobs does Adaptive Phage Therapeutics sponsor for H-1B?
- Adaptive Phage Therapeutics's most-sponsored H-1B roles include Project Manager, Project & Alliance Management.
- Where does Adaptive Phage Therapeutics hire H-1B workers?
- Adaptive Phage Therapeutics's top H-1B worksite states are MD.
Calculate your H-1B lottery odds →orCheck out the insights →